Published on
August 6, 2025
- 17:00 GMT
Project Alive Urges FDA to Prioritize Approvals for Life-Saving Rare Disease Treatments
The organization is reaching out to the FDA for support CRESTLINE, CA, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Kristin McKay, President and Executive Director of Project Alive, is calling on the U.S. Food and Drug Administration (FDA …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Human Rights
...
